Safety, tolerability, and preliminary efficacy of ascending doses of Human Allogeneic Liver-derived Progenitor Cells (HepaStem?) in patients with cirrhotic and pre-cirrhotic non-alcoholic steatohepatitis (NASH)
JOURNAL OF HEPATOLOGY(2023)
关键词
progenitor cells,liver-derived,pre-cirrhotic,non-alcoholic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要